Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Willy Haukeland

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vitamins and Hormones|March 1, 2011
Activin A in nonalcoholic fatty liver diseaseArne Yndestad, John Willy Haukeland, Tuva B Dahl, et al.
Scandinavian Journal of Gastroenterology|December 5, 2012
Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liverHans Lannerstedt, Zbigniew Konopski, Leiv Sandvik, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 13, 2022
[Transjugular intrahepatic portosystemic shunt for portal hypertension]John Willy Haukeland, Håvard Midgard, Zbigniew Konopski, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 29, 2021
Diagnosis and treatment of autoimmune hepatitisMette Vesterhus, Kristine Wiencke, John Willy Haukeland, et al.
Scandinavian Journal of Gastroenterology|November 19, 2005
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver diseaseJohn Willy Haukeland, Zbigniew Konopski, Paul Linnestad, et al.
Plos One|March 13, 2020
Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in NorwayJohn Willy Haukeland, Milada Cvancarova Småstuen, Pia Pernille Pålsdatter, et al.
Medical Ultrasonography|March 15, 2013
Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver DiseaseHilde Løland von Volkmann, Roald Flesland Havre, Else Marit Løberg, et al.
Scandinavian Journal of Gastroenterology|October 9, 2009
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trialJohn Willy Haukeland, Zbigniew Konopski, Heidi Beate Eggesbø, et al.
Journal of Hepatology|April 19, 2006
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2John Willy Haukeland, Jan Kristian Damås, Zbigniew Konopski, et al.
Clinical and Translational Gastroenterology|July 3, 2015
Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic InflammationKari Otterdal, John Willy Haukeland, Arne Yndestad, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vitamins and Hormones|March 1, 2011
Activin A in nonalcoholic fatty liver diseaseArne Yndestad, John Willy Haukeland, Tuva B Dahl, et al.
Scandinavian Journal of Gastroenterology|December 5, 2012
Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liverHans Lannerstedt, Zbigniew Konopski, Leiv Sandvik, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 13, 2022
[Transjugular intrahepatic portosystemic shunt for portal hypertension]John Willy Haukeland, Håvard Midgard, Zbigniew Konopski, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 29, 2021
Diagnosis and treatment of autoimmune hepatitisMette Vesterhus, Kristine Wiencke, John Willy Haukeland, et al.
Scandinavian Journal of Gastroenterology|November 19, 2005
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver diseaseJohn Willy Haukeland, Zbigniew Konopski, Paul Linnestad, et al.
Plos One|March 13, 2020
Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in NorwayJohn Willy Haukeland, Milada Cvancarova Småstuen, Pia Pernille Pålsdatter, et al.
Medical Ultrasonography|March 15, 2013
Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver DiseaseHilde Løland von Volkmann, Roald Flesland Havre, Else Marit Løberg, et al.
Scandinavian Journal of Gastroenterology|October 9, 2009
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trialJohn Willy Haukeland, Zbigniew Konopski, Heidi Beate Eggesbø, et al.
Journal of Hepatology|April 19, 2006
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2John Willy Haukeland, Jan Kristian Damås, Zbigniew Konopski, et al.
Clinical and Translational Gastroenterology|July 3, 2015
Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic InflammationKari Otterdal, John Willy Haukeland, Arne Yndestad, et al.
Pageof 2